Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study

May-16

AUTHORS : Dr Miriam Sturkenboom, Julius Global Health, University Medical Center Utrecht, Heidelberglaan 100, the Netherlands – Email: m.c.j.sturkenboom@umcutrecht.nl – Profile: https://www.umcutrecht.nl/en/research/researchers/sturkenboom-miriam-mcjm – Contact is Dr Preciosa M. Coloma (Details for study: Department of Medical Informatics, Erasmus MC University Medical Center Rotterdam – Email: p.coloma@erasmusmc.nl) but she is no longer working there and I can’t find her updated contact details (https://biosemantics.erasmusmc.nl/index.php/members?view=member&task=show&id=8)

JOURNAL : Osteoporosis International

REFERENCE: 27(5):1857-67

DOI : 10.1007/s00198-015-3441-2

Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study